Detection and management of early Pseudomonas aeruginosa infection in patients with cystic fibrosis;Détection et prise en charge précoce de la primo-infection à «Pseudomonas aeruginosa» chez les patients avec mucoviscidose

Revue Medicale Suisse

Volumn 1, Issue 9, 2005, Pages 637-640

  Kernen, Yann ^a   Roulet, Michel ^a   Sauty, Alain ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; TOBRAMYCIN; ANTIINFECTIVE AGENT;

CYSTIC FIBROSIS; DRUG EFFICACY; HUMAN; LUNG INFECTION; PSEUDOMONAS AERUGINOSA; REVIEW; SPUTUM CULTURE; TREATMENT OUTCOME; GRAM NEGATIVE INFECTION;

ANTI-BACTERIAL AGENTS; CYSTIC FIBROSIS; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 18744417246     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. Ratjen F, Döring G. Cystic Fibrosis. Lancet 2003;361:681-9.
2. Döring G, Hoiby N, for the consensus study group. Early intervention and prevention of lung disease in cystic fibrosis: A European consensus. J Cyst Fibros 2004;3:67-9l.
3. During G, Conway S, Heijerman H, et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: A European consensus. Eur Respir J 2000;16:749-67.
4. Gibson R, Burns J, Ramsey B. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003;168:918-51.
5. Ramsey B, et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. N Engl J Med 1999;340:23-30.
6. Suri R, Marshal L, Wallis C, et al. Safety and use of sputum induction in children with cystic fibrosis. Pediatr Pulmonol 2003;35:309-13.
7. Saiman L, Burns J, Larone D, et al. Evaluation of MicroScan Autoscan for identification of Pseudomonas aeruginosa isolates from cystic fibrosis patients. J Clin Microbiol 2003;41:492-4.
8. Rosenfeld M, Ramsey B, Gibson R. Pseudomonas acquisition in young patients with cystic fibrosis: Pathophysiology, diagnosis and management. Curr Opin Pulm Med 2003;9:492-7.
9. Gibson R. Anti-pseudomonal approaches to CF. Comparing consensus with clinical practice. ECFC Symposium 2004, Birmingham.
10. Döring G, Dorner F. A multicenter vaccine trial using the Pseudomonas aeruginosa flagella vaccine IMMUNO in patients with cystic fibrosis. Behring Inst Mitt 1997;98:338-44.
11. Lang A, Rüdeberg A, Schöni M, et al. Vaccination of cystic fibrosis patients against pseudomonas aeruginosa reduces the proportion of patients infected and delays time of infection. Pediatr Infect Dis J 2004;23:504-10.